{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T21:56:50Z","timestamp":1783634210369,"version":"3.55.0"},"reference-count":91,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2006,1,12]],"date-time":"2006-01-12T00:00:00Z","timestamp":1137024000000},"content-version":"vor","delay-in-days":407,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of the New York Academy of Sciences"],"published-print":{"date-parts":[[2004,12]]},"abstract":"<jats:p><jats:bold>A<jats:sc>bstract<\/jats:sc>: <\/jats:bold> Although hormones produced in the body are normally considered to be beneficial in such matters as life, male and female development, fertility, and blood pressure regulation, these same compounds can act in some circumstances as carcinogens or carcinogen facilitators, In some such cases increased amounts of the hormone or changes in the formation of its metabolites might be responsible. In other cases the timing of hormone release plays a critical role. In some cases the hormone acts independently, while in others two or more compounds act in concert to promote cancer. The various compounds will be discussed separately, since they usually cause different kinds of cancer. Of the various hormones produced in the body, only aldosterone does not cause any cancers, although excess aldosterone can cause Conn's syndrome, which may be detected by the resultant hypertension.<\/jats:p>","DOI":"10.1196\/annals.1322.027","type":"journal-article","created":{"date-parts":[[2005,1,13]],"date-time":"2005-01-13T20:08:46Z","timestamp":1105646926000},"page":"216-232","source":"Crossref","is-referenced-by-count":11,"title":["Steroids as Procarcinogenic Agents"],"prefix":"10.1111","volume":"1028","author":[{"given":"H LEON","family":"BRADLOW","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"DANIEL W.","family":"SEPKOVIC","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2006,1,12]]},"reference":[{"key":"e_1_2_8_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0889-1591(02)00060-0"},{"key":"e_1_2_8_3_2","first-page":"S73","article-title":"Hypothalamic\u2010pituitary\u2010adrenal alterations in PTSD: are they relevant to understanding cortisol alterations in cancer? Brain Behav","volume":"17","author":"Yehuda R.","year":"2003","journal-title":"Immun"},{"key":"e_1_2_8_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0889-1591(02)00062-4"},{"key":"e_1_2_8_5_2","unstructured":"Richter R. 2000. Stress hormone may contribute to breast cancer deaths. Stanford online report issue of June 28."},{"key":"e_1_2_8_6_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.PSY.0000088595.91705.C5"},{"key":"e_1_2_8_7_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/92.12.994"},{"key":"e_1_2_8_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0889-1591(02)00063-6"},{"key":"e_1_2_8_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0889-1591(02)00068-5"},{"key":"e_1_2_8_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0889-1591(02)00058-2"},{"key":"e_1_2_8_11_2","doi-asserted-by":"publisher","DOI":"10.1177\/00912709922008182"},{"key":"e_1_2_8_12_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-003-0690-3"},{"key":"e_1_2_8_13_2","first-page":"237","article-title":"Epidemiological study of the urinary 6 beta\u2010hydroxycortisol to cortisol ratio and breast cancer risk","volume":"10","author":"Zheng W.","year":"2001","journal-title":"Cancer Epidemiol. Biomarkers Prev"},{"key":"e_1_2_8_14_2","unstructured":"Lee J. 1993. Natural Progesterone\u2010Multiple Roles of a Remarkable Hormone. BLL Publ. Sebastopol CA."},{"key":"e_1_2_8_15_2","first-page":"731","volume":"272","author":"Weiler P.J.","year":"2000","journal-title":"Plasma membrane receptors for the cancer-regulating progesterone metabolites, 5-pregnane-3,20-dione and 3-hydroxy-4-pregnen-20-one in mcf-7 breast cancer cells biochemical and biophysical research communications"},{"key":"e_1_2_8_16_2","doi-asserted-by":"publisher","DOI":"10.1186\/bcr451"},{"key":"e_1_2_8_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsbmb.2003.08.004"},{"key":"e_1_2_8_18_2","first-page":"5236","article-title":"A functional polymorphism in the progesterone receptor gene is associated with an increase in breast cancer risk","volume":"63","author":"Vivo I.","year":"2003","journal-title":"Cancer Res"},{"key":"e_1_2_8_19_2","doi-asserted-by":"publisher","DOI":"10.1210\/en.142.12.5236"},{"key":"e_1_2_8_20_2","doi-asserted-by":"publisher","DOI":"10.1186\/bcr556"},{"key":"e_1_2_8_21_2","first-page":"2572","article-title":"Serum and urinary androgens and the risk of breast cancer in postmenopausal women","volume":"51","author":"Secreto G.","year":"1991","journal-title":"Cancer Res"},{"key":"e_1_2_8_22_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a009059"},{"key":"e_1_2_8_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1078-1439(03)00004-8"},{"key":"e_1_2_8_24_2","doi-asserted-by":"crossref","unstructured":"Thigpen A.E. R.I. Silver J.M. Guileyardo et al.1993. Tissue distribution and ontogeny of steroid 5 alpha\u2010reductase isozyme expression. J. Clin. Invest.92(2): 903\u2013910.","DOI":"10.1172\/JCI116665"},{"key":"e_1_2_8_25_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.11126"},{"key":"e_1_2_8_26_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.pcan.4500421"},{"key":"e_1_2_8_27_2","doi-asserted-by":"publisher","DOI":"10.1002\/pros.10140"},{"key":"e_1_2_8_28_2","doi-asserted-by":"publisher","DOI":"10.1002\/pros.10234"},{"key":"e_1_2_8_29_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.pcan.4500599"},{"key":"e_1_2_8_30_2","doi-asserted-by":"crossref","unstructured":"McLeod D.G. 2003. Hormonal therapy: historical perspective to future directions. Urology61(2Suppl.1): 3\u20137.","DOI":"10.1016\/S0090-4295(02)02393-2"},{"key":"e_1_2_8_31_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1464-410X.2003.04133.x"},{"key":"e_1_2_8_32_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/93.22.1739"},{"key":"e_1_2_8_33_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djg009"},{"key":"e_1_2_8_34_2","first-page":"2734","article-title":"Effect of isocaloric low\u2010fat diet on human LAPC\u20104 prostate cancer xenografts in severe combined immunodeficient mice and the insulin\u2010like growth factor axis","volume":"9","author":"Ngo T.H.","year":"2003","journal-title":"Clin. Cancer Res"},{"key":"e_1_2_8_35_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa030660"},{"key":"e_1_2_8_36_2","unstructured":"Zeigler\u2010Johnson C. CYP3A4: A potential prostate cancer risk factor for high\u2010risk groups. Clin. J. Oncol. Nursing5:4. 2003"},{"key":"e_1_2_8_37_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/90.16.1225"},{"key":"e_1_2_8_38_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.pcan.4500417"},{"key":"e_1_2_8_39_2","first-page":"1410","article-title":"Endogenous sex hormones and prosate cancer risk: a case\u2010control study nested within the Carotene and Retinol Efficacy Study","volume":"12","author":"Chan C.","year":"2003","journal-title":"Cancer Epidemiol. Biomarkers Prev"},{"key":"e_1_2_8_40_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1021986811425"},{"key":"e_1_2_8_41_2","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.23.1.104-118.2003"},{"key":"e_1_2_8_42_2","first-page":"1095","article-title":"The androgen receptor in hormone refractory prostate cancer: relevance of different mechanisms of androgen receptor signaling","volume":"23","author":"Cronauer M.V.","year":"2003","journal-title":"Int. J. Oncol"},{"key":"e_1_2_8_43_2","first-page":"621","article-title":"Serum androgens and prostate cancer","volume":"5","author":"Nomura A.M.","year":"1996","journal-title":"Cancer Epidemiol. Biomarkers Prev"},{"key":"e_1_2_8_44_2","doi-asserted-by":"publisher","DOI":"10.1210\/er.2002-0032"},{"key":"e_1_2_8_45_2","doi-asserted-by":"publisher","DOI":"10.1002\/j.1939-4640.2003.tb02727.x"},{"key":"e_1_2_8_46_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.11607"},{"key":"e_1_2_8_47_2","doi-asserted-by":"crossref","unstructured":"Calhoun E. R.F. Pommier P. Muller et al.Dehydroepiandrosterone sulfate causes proliferation of estrogen receptor\u2010positive breast cancer cells despite treatment with fulvestrant Arch. Surg.138:879\u2010883. 2003.","DOI":"10.1001\/archsurg.138.8.879"},{"key":"e_1_2_8_48_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0303-7207(00)00442-1"},{"key":"e_1_2_8_49_2","doi-asserted-by":"publisher","DOI":"10.1159\/000055283"},{"key":"e_1_2_8_50_2","first-page":"164","article-title":"Inhibition of 7, 12\u2010dimethylbenz(a)anthracene\u2010induced skin papillomas and carcinomas by dehydroepiandrosterone and 3\u2013methylandrost\u20105\u2010en\u201017\u2010one in mice","volume":"45","author":"Pashko L.L.","year":"1985","journal-title":"Cancer Res"},{"key":"e_1_2_8_51_2","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/22.2.301"},{"key":"e_1_2_8_52_2","first-page":"33","article-title":"Serum Levels of DHEA and DHEAS and the risk of developing gastric cancer","volume":"2","author":"Gordon G.B.","year":"1993","journal-title":"Cancer Epidemiol. Biomarkers Prev"},{"key":"e_1_2_8_53_2","doi-asserted-by":"publisher","DOI":"10.1006\/frne.2001.0216"},{"key":"e_1_2_8_54_2","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.30.5.570"},{"key":"e_1_2_8_55_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2003-031847"},{"key":"e_1_2_8_56_2","first-page":"47","article-title":"Estrogenic effects of physiological concentrions of androstene\u20103, 17\u2010diol and its metabolism in MCF\u20107 human breast cancer cells","volume":"41","author":"Adams J.B.","year":"1979","journal-title":"Cancer Res"},{"key":"e_1_2_8_57_2","doi-asserted-by":"publisher","DOI":"10.3109\/07853899709113696"},{"key":"e_1_2_8_58_2","first-page":"647","article-title":"Developing a marker of exposure to xenoestrogen mixtures in hmn serum","volume":"105","author":"Soto A.M.","year":"1997","journal-title":"Environ. Health Perspec"},{"key":"e_1_2_8_59_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0463.2001.tb00013.x"},{"key":"e_1_2_8_60_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.85.21.7831"},{"key":"e_1_2_8_61_2","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/23.6.1071"},{"key":"e_1_2_8_62_2","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/bgg047"},{"key":"e_1_2_8_63_2","doi-asserted-by":"crossref","unstructured":"Telang N.T. A. Basu G.Y. Wong et al.1993. Chemopreventive modulation of human mammary carcinogenesis by bioactive lipids.InEicosanoids and Other Bioactive Lipids in Cancer Inflammation and Radiation Injury. S. Nigam L.L.J. Marnett K.V. Honn and T.L. Walden Jr. Eds.: 440\u2010446. Kluwer Academic Publishers. Boston.","DOI":"10.1007\/978-1-4615-3520-1_87"},{"key":"e_1_2_8_64_2","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/12.9.1571"},{"key":"e_1_2_8_65_2","first-page":"337","article-title":"Estrogen metabolism and human papillomavirus\u2010induced tumors of the larynx: chemoprophylaxis with indole\u20103\u2010carbinol","volume":"13","author":"Newfield L.","year":"1993","journal-title":"Anticancer Res"},{"key":"e_1_2_8_66_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01806529"},{"key":"e_1_2_8_67_2","doi-asserted-by":"crossref","unstructured":"Bradlow H.L. N.T. Telang & M.P. Osborne. 1996. Estrogen metabolites as bioreactive modulators of tumor initiators and promoters. Proceedings of the 5th international symposium on bioreactive molecules.InBiologically Reactive Intermediates Vol. 5. R. Snyder et al. Eds. Plenum Press. New York.","DOI":"10.1007\/978-1-4757-9480-9_37"},{"key":"e_1_2_8_68_2","first-page":"709","article-title":"Chemoprevention of chemically\u2010induced mammary carcinogenesis by indole\u20103\u2010carbinol","volume":"15","author":"Grubbs C.J.","year":"1995","journal-title":"Anticancer Res"},{"key":"e_1_2_8_69_2","doi-asserted-by":"publisher","DOI":"10.1006\/gyno.2000.5847"},{"key":"e_1_2_8_70_2","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/S0194-5998(98)70274-8","article-title":"Preliminary results of the use of indole\u20103\u2010carbinol for recurrent respiratory papillomatosis","volume":"118","author":"Rosen C.A.","year":"1998","journal-title":"Otolaryngology"},{"key":"e_1_2_8_71_2","first-page":"1673","article-title":"Antiestrogenic activities of indole\u20103\u2010carbinol in cervical cells: implication for prevention of cervical cancer","volume":"19","author":"Yuan F.","year":"1999","journal-title":"Anticancer Res"},{"key":"e_1_2_8_72_2","doi-asserted-by":"publisher","DOI":"10.1067\/mhn.2001.113507"},{"key":"e_1_2_8_73_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsbmb.2004.01.006"},{"key":"e_1_2_8_74_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.79.9.3047"},{"key":"e_1_2_8_75_2","first-page":"505","article-title":"Urinary estrogen metabolites and breast cancer: a case\u2010control study","volume":"6","author":"Kabat G.C.","year":"1997","journal-title":"Cancer Epidemiol. Biomarkers Prev"},{"key":"e_1_2_8_76_2","first-page":"294","article-title":"Urinary 2\/16 alpha\u2010hydroxyestrone ratio: correlation with serum insulin\u2010like growth factor binding protein\u20103 and a potential biomarker of breast cancer risk","volume":"27","author":"Ho G.H.","year":"1998","journal-title":"Ann. Acad. Med. Singapore"},{"key":"e_1_2_8_77_2","first-page":"505","article-title":"Correspondence re: G.C. Kabat et al., Urinary estrogen metabolites and breast cancer: a case\u2010control study. Cancer Epidemiol","volume":"6","author":"Zheng W.","year":"1997","journal-title":"Biomarkers Prev"},{"key":"e_1_2_8_78_2","first-page":"35","article-title":"The prognostic value of altered estrogen metabolism in breast cancer","volume":"7","author":"Dupont E.","year":"2000","journal-title":"Ann. Surg. Oncol"},{"key":"e_1_2_8_79_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0039-128X(02)00116-2"},{"key":"e_1_2_8_80_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2003-41357"},{"key":"e_1_2_8_81_2","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1998.663"},{"key":"e_1_2_8_82_2","unstructured":"Dupont E. T. Klug C. McCann et al.2000. The prognostic value of altered estrogen metabolism in breast cancer. Ann. Surg. Oncol.7(suppl P): 35."},{"key":"e_1_2_8_83_2","first-page":"689","article-title":"Estrogen metabolite ratios as biomarkers of hormonally related breast cancer risk","volume":"42","author":"Fleisher M.","year":"1996","journal-title":"Clin. Chem"},{"key":"e_1_2_8_84_2","doi-asserted-by":"publisher","DOI":"10.1097\/00001648-200011000-00004"},{"key":"e_1_2_8_85_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3835(03)00014-4"},{"key":"e_1_2_8_86_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/91.12.1067"},{"key":"e_1_2_8_87_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/86.14.1076"},{"key":"e_1_2_8_88_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.ede.0000091607.77374.74"},{"key":"e_1_2_8_89_2","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.23.21.7920-7925.2003"},{"key":"e_1_2_8_90_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cdp.2003.11.006"},{"key":"e_1_2_8_91_2","doi-asserted-by":"publisher","DOI":"10.1289\/ehp.7028"},{"key":"e_1_2_8_92_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.toxlet.2004.01.018"}],"container-title":["Annals of the New York Academy of Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1196%2Fannals.1322.027","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/nyaspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1196\/annals.1322.027","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T17:29:02Z","timestamp":1695662942000},"score":1,"resource":{"primary":{"URL":"https:\/\/nyaspubs.onlinelibrary.wiley.com\/doi\/10.1196\/annals.1322.027"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,12]]},"references-count":91,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2004,12]]}},"alternative-id":["10.1196\/annals.1322.027"],"URL":"https:\/\/doi.org\/10.1196\/annals.1322.027","archive":["Portico"],"relation":{},"ISSN":["0077-8923","1749-6632"],"issn-type":[{"value":"0077-8923","type":"print"},{"value":"1749-6632","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,12]]}}}